Author Correction: Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK

David Danielpour; Zhaofeng Gao; Patrick M Zmina; Eswar Shankar; Benjamin C Shultes; Raul Jobava; Scott M Welford; Maria Hatzoglou

doi:10.1038/s41598-019-51007-0

Back

Author Correction: Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK

Journal article

Open access

Peer reviewed

Author Correction: Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK

David Danielpour, Zhaofeng Gao, Patrick M Zmina, Eswar Shankar, Benjamin C Shultes, Raul Jobava, Scott M Welford and Maria Hatzoglou

Scientific reports, Vol.9(1), pp.14826-2

2019-10-10

DOI: https://doi.org/10.1038/s41598-019-51007-0

PMCID: PMC6785556

PMID: 31597941

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Files and links (1)

url

https://doi.org/10.1038/s41598-019-51007-0View

Published (Version of record) Open

Metrics

9 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.25 Molecular & Cell Biology - Cancer, Autophagy & Apoptosis; 1.25.134 Apoptosis
Web Of Science research areas: Biochemistry & Molecular Biology
ESI research areas: Molecular Biology & Genetics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Author Correction: Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK
Creators: David Danielpour - Department of Urology, University Hospitals of Cleveland, Cleveland, OH, 44106, USA. dxd49@case.edu
Zhaofeng Gao - Department of Genetics and Genomic Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA
Patrick M Zmina - Case Comprehensive Cancer Center Research Laboratories, The Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, OH, 44106, USA
Eswar Shankar - Case Comprehensive Cancer Center Research Laboratories, The Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, OH, 44106, USA
Benjamin C Shultes - Department of Biochemistry, Case Western Reserve University, Cleveland, OH, 44106, USA
Raul Jobava - Department of Genetics and Genomic Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA
Scott M Welford - Department of Radiation Oncology, University of Miami, Coral Gables, FL, 33136, USA
Maria Hatzoglou - Department of Genetics and Genomic Sciences, Case Western Reserve University, Cleveland, OH, 44106, USA
Publication Details: Scientific reports, Vol.9(1), pp.14826-2
Grant note: R37 DK060596 / NIDDK NIH HHS R01 DK060596 / NIDDK NIH HHS
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
PMID: 31597941
PMCID: PMC6785556
Record Identifier: 991031614896002976